Verition Fund Management
CASI

Verition Fund Management’s CASI Pharmaceuticals CASI Stock Holding History

Verition Fund Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,584
Closed -$66K – 1099
2018
Q1 		$66K Buy
+1,584
New +$59.1K ﹤0.01% 1069

Other funds holding CASI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Verition Fund Management's CASI Position: Q2 2018 in Review

Verition Fund Management sold out of CASI Pharmaceuticals (CASI) in Q2 2018, closing a stake of 1,584 shares — an estimated $66K sold.

Verition Fund Management first reported a position in CASI in Q1 2018 and held it in 1 quarter. The position peaked at $66K in Q1 2018. 57 funds tracked by Wall St. Rank hold CASI as of Q2 2018.

  • Verition Fund Management reported no remaining CASI Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Verition Fund Management sold 1,584 CASI Pharmaceuticals shares in Q2 2018, an estimated $66K.
  • Verition Fund Management first reported a position in CASI Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Verition Fund Management's CASI Pharmaceuticals position peaked at $66K in Q1 2018.
  • 57 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2018.

Based on Verition Fund Management's 13F filing for Q2 2018, filed 15 Aug 2018.